MOTS-C is supplied strictly as a laboratory research material. It is not approved, intended or authorised for human consumption or any therapeutic use. This article summarises published preclinical research for qualified researchers and is not medical advice.
A hidden genome that codes for peptides
Almost every cell in the body carries two genomes: the familiar nuclear DNA, and a small circular chromosome inside the mitochondria. For a long time the mitochondrial genome was thought to encode just 13 proteins, all tied to energy production. That picture changed when researchers found short open reading frames — hidden within known mitochondrial genes — that produce their own bioactive peptides. These are the mitochondrial-derived peptides (MDPs): humanin was the first, followed by the SHLP family, and then MOTS-C.
What makes MDPs interesting is that they behave like signals. Rather than staying inside the mitochondrion, they can move into the cytoplasm and even the nucleus, and they circulate in the blood. In effect, the mitochondria appear to "talk back" to the rest of the cell about its metabolic state — a form of retrograde signalling that researchers are still mapping.
What is MOTS-C?
MOTS-C — short for Mitochondrial ORF of the Twelve S rRNA type-C — is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene. It was first described in 2015 by a team led by researchers at USC, and it quickly stood out because of where it acts and what it does. Unlike many peptides that work at the cell surface, MOTS-C can translocate to the nucleus under metabolic stress and help regulate the expression of genes involved in the cell's stress and antioxidant responses.
Its headline mechanism in the literature is activation of the AMPK pathway — AMP-activated protein kinase, often described as the cell's master energy sensor. When cellular energy runs low, AMPK switches on catabolic, energy-generating programmes and dials down energy-consuming ones. By engaging this pathway, MOTS-C has been reported in preclinical models to influence how cells handle glucose and fat.
16 amino acids · encoded in the mitochondrial 12S rRNA gene · discovered 2015 · activates the AMPK energy-sensing pathway · promotes GLUT4-mediated glucose uptake in preclinical models · induced by exercise · circulating levels decline with age.
Glucose, AMPK and the "exercise-mimetic" framing
The finding that drew the most attention is MOTS-C's effect on glucose handling. In cell and animal studies, MOTS-C promotes GLUT4-mediated glucose uptake into muscle — GLUT4 being the transporter that normally moves glucose into cells in response to insulin and exercise. In mouse models of diet-induced metabolic stress, MOTS-C administration was associated with improved insulin sensitivity and reduced weight gain.
Two observations pushed MOTS-C into longevity and exercise research. First, physical exercise induces MOTS-C: levels rise in muscle and circulation following exertion, consistent with its role as a signal tied to energy demand. Second, circulating MOTS-C declines with age. Together these gave rise to the research framing of MOTS-C as a potential "exercise-mimetic" — a molecule that engages some of the same energy-sensing machinery that exercise does. It's an appealing shorthand, but it remains a research hypothesis: the human data are early, and no peptide reproduces the full systemic benefit of actual exercise.
Why MDPs matter for metabolic and longevity research
MOTS-C is important partly in its own right and partly as a doorway into a broader idea. If the mitochondrial genome encodes a suite of signalling peptides that decline with age and respond to metabolic stress, then MDPs may represent a previously overlooked layer of communication between mitochondria and the rest of the body. That has obvious relevance to conditions where mitochondrial function falters — insulin resistance, metabolic syndrome and the general decline of ageing. For researchers, MOTS-C is a tractable tool for probing AMPK signalling, glucose metabolism and mitochondrial stress responses in the lab. You can find a fuller technical breakdown on our MOTS-C profile, and related material across the peptide knowledgebase.
Buying considerations for research-grade MOTS-C
Because MOTS-C is a small peptide, quality control matters as much as it does for any research reagent. A few things separate serious material from the rest:
- Verified purity. Research-grade MOTS-C should be ≥99% pure, confirmed by independent HPLC rather than the seller's own claim. Small peptides are prone to synthesis by-products, so the analytical method matters.
- A Certificate of Analysis (COA) per batch. A genuine COA ties a specific lot to its identity (mass spectrometry) and purity (HPLC) data. If a supplier can't produce one, that's a reason to look elsewhere.
- Correct presentation. MOTS-C should ship as a sterile lyophilised (freeze-dried) powder in a sealed vial, to be reconstituted only for research use. Watch for pre-mixed vials of unknown concentration.
- Compliant framing. A reputable research supplier will never offer human dosing guidance or therapeutic claims for MOTS-C. That restraint is a sign of a serious operation, not a limitation.
At RS Bio Labs, MOTS-C is supplied at ≥99% purity, lyophilised, with a per-batch COA and free UK shipping. Live pricing is on our buy MOTS-C UK page.
The bottom line
MOTS-C is the flagship example of a genuinely new peptide class — signals written into mitochondrial DNA that respond to exercise, engage the AMPK energy sensor and fade with age. The science is still young and firmly preclinical, but MDPs have opened a fresh line of enquiry into how mitochondria shape metabolism and ageing. For researchers, that makes MOTS-C one of the more compelling tools to have on the bench — provided it comes with the purity and paperwork to back it.